Medical Partnership Modernizes Oxygen Delivery
A gauge measures oxygen flow during testing of a Deployable Oxygen Concentration System at Fort Detrick, Maryland, Aug. 10, 2022. The U.S. Army Medical Materiel Development Activity’s Warfighter Deployed Medical Systems, the U.S. Army Medical Test and Evaluation Activity (USAMTEAC), and Soldiers with the 551st Medical Logistics Company and 51st MLC partnered at Fort Detrick to assess three commercially available medical-grade oxygen generating systems. The medical logistics and biomedical equipment specialists’ job during testing is to ensure the oxygen generators meet the Army’s standards for performance in field-like conditions. USAMMDA is a subordinate command of the U.S. Army Medical Research and Development Command, under the Army Futures Command. As the premier developer of world-class military medical capabilities, USAMMDA is responsible for developing and delivering critical products designed to protect and preserve the lives of Warfighters across the globe. These products include drugs, vaccines, biologics, devices and medical support equipment intended to maximize survival of casualties on the battlefield. (U.S. Army Photo by T. T. Parish/Released)
